Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618981.RAR3Buxc_3Gnf-uYB3t3C1TLyvPyHsv_W5mmkw2sa4S1E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618981.RAR3Buxc_3Gnf-uYB3t3C1TLyvPyHsv_W5mmkw2sa4S1E130_assertion type Assertion NP618981.RAR3Buxc_3Gnf-uYB3t3C1TLyvPyHsv_W5mmkw2sa4S1E130_head.
- NP618981.RAR3Buxc_3Gnf-uYB3t3C1TLyvPyHsv_W5mmkw2sa4S1E130_assertion description "[Their levels fell further with increasing tumour's stage and were higher in tumours from patients who remained disease free compared with those who developed local recurrence or distant metastasis or died from breast cancer.TRF2 showed a trend similar to that of TANK2 and POT1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618981.RAR3Buxc_3Gnf-uYB3t3C1TLyvPyHsv_W5mmkw2sa4S1E130_provenance.
- NP618981.RAR3Buxc_3Gnf-uYB3t3C1TLyvPyHsv_W5mmkw2sa4S1E130_assertion evidence source_evidence_literature NP618981.RAR3Buxc_3Gnf-uYB3t3C1TLyvPyHsv_W5mmkw2sa4S1E130_provenance.
- NP618981.RAR3Buxc_3Gnf-uYB3t3C1TLyvPyHsv_W5mmkw2sa4S1E130_assertion SIO_000772 17616810 NP618981.RAR3Buxc_3Gnf-uYB3t3C1TLyvPyHsv_W5mmkw2sa4S1E130_provenance.
- NP618981.RAR3Buxc_3Gnf-uYB3t3C1TLyvPyHsv_W5mmkw2sa4S1E130_assertion wasDerivedFrom befree-2016 NP618981.RAR3Buxc_3Gnf-uYB3t3C1TLyvPyHsv_W5mmkw2sa4S1E130_provenance.
- NP618981.RAR3Buxc_3Gnf-uYB3t3C1TLyvPyHsv_W5mmkw2sa4S1E130_assertion wasGeneratedBy ECO_0000203 NP618981.RAR3Buxc_3Gnf-uYB3t3C1TLyvPyHsv_W5mmkw2sa4S1E130_provenance.